Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017, Article ID 5651064, 3 pages
Case Report

Recurrence of Chronic Myeloid Leukemia during Pregnancy Subsequently Achieving Complete Medical Remission

Department of Obstetrics and Gynecology, Providence Hospital, Michigan State University College of Human Medicine, East Lansing, MI, USA

Correspondence should be addressed to Sasha Mikhael; moc.liamg@leahkim.ahsas

Received 2 May 2017; Accepted 2 July 2017; Published 3 August 2017

Academic Editor: Jose I. Mayordomo

Copyright © 2017 Sasha Mikhael et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Pavlovsky, I. Giere, and G. Van Thillo, “Planned pregnancy in a chronic myeloid leukemia patient in molecular remission,” Case Reports in Hematology, vol. 2012, Article ID 624590, 4 pages, 2012. View at Publisher · View at Google Scholar
  2. H. Alizadeh, H. Jaafar, and B. Kajtár, “Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports,” Annals of Saudi Medicine, vol. 35, no. 6, pp. 468–471, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Martin, A. Ramesh, L. Devadasan, Palaniappan, and J. J. Martin, “An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib,” Indian Journal of Medical and Paediatric Oncology, vol. 32, no. 2, pp. 109–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. F.-X. Mahon, D. Réa, J. Guilhot et al., “Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial,” The Lancet Oncology, vol. 11, no. 11, pp. 1029–1035, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. V. Melo and D. M. Ross, “Minimal residual disease and discontinuation of therapy in chronic myeloid leukemia: can we aim at a cure?” Hematology, vol. 2011, no. 1, pp. 136–142, 2011. View at Publisher · View at Google Scholar
  6. E. Abruzzese, M. M. Trawinska, P. De Fabritiis, and A. P. Perrotti, “TYrosine kinase inhibitors and pregnancy,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 6, no. 1, Article ID 2014028, 2014. View at Publisher · View at Google Scholar